Pfizer Says its Experimental COVID-19 Pill Reduced Risk of Hospitalization or Death by 90%
November 5, 2021Comments Off
Pfizer Inc. announced this week its investigational novel COVID-19 oral antiviral candidate, PAXLOVID™, significantly reduced hospitalization and death, based on an interim analysis of the Phase…